# Phase 6C: Tier 2 Live Capacity Validation Report

## FINAL VERDICT: `TIER2_VALIDATED`

```
================================================================================
FINAL VERDICT: TIER2_VALIDATED
PHASE 6C CONTROLLED CAPITAL RAMP & CAPACITY VALIDATION
================================================================================
```

---

## 1. Executive Summary & Core Results

Phase 6C successfully executed the controlled live capacity evaluation of the frozen Alpha A champion strategy under **Tier 2 ($5,000 USD)** authorized capital. Following formal human governance authorization, the platform executed **192 autonomous live fills across 32 consecutive trading sessions** under `ExecutionMode.LIVE_AUTONOMOUS_MICRO`.

### Key Empirical Findings (Tier 0 vs Tier 1 vs Tier 2)

| Metric | Tier 0 ($1,000 Baseline) | Tier 1 ($2,500 Validated) | Tier 2 ($5,000 Validated) | Tier 2 Delta vs Tier 0 | Evidence Type |
| :--- | :--- | :--- | :--- | :--- | :--- |
| **Capital Allocation** | $1,000.00 USD | $2,500.00 USD | **$5,000.00 USD** | +400% (5.0x) | `LIVE_AUTONOMOUS` |
| **Completed Live Fills** | 216 fills | 164 fills | **192 fills** | - | `LIVE_AUTONOMOUS` |
| **Completed Sessions** | 45 sessions | 25 sessions | **32 sessions** | - | `LIVE_AUTONOMOUS` |
| **Gross Alpha** | +4.92 bps/trade | +4.91 bps/trade | **+4.89 bps/trade** | -0.03 bps | `LIVE_AUTONOMOUS` |
| **Total Friction** | 3.35 bps/trade | 3.44 bps/trade | **3.58 bps/trade** | +0.23 bps | `LIVE_AUTONOMOUS` |
| **Net Expectancy** | **+1.57 bps/trade** | **+1.47 bps/trade** | **+1.31 bps/trade** | **-0.26 bps** | `LIVE_AUTONOMOUS` |
| **95% Confidence Interval**| [+1.02, +2.12] bps | [+0.95, +1.99] bps | **[+0.74, +1.88] bps** | - | `LIVE_AUTONOMOUS` |
| **Absolute Edge Retention**| 100.0% (Reference) | 93.6% | **83.4%** | -16.6% | **`HEALTHY_CAPACITY`** ($\ge 80\%$) |
| **Incremental Retention** | 100.0% | 93.6% | **89.1%** | -10.9% | Retention vs Tier 1 |
| **Implementation Shortfall**| 1.41 bps | 1.48 bps | **1.58 bps** | +0.17 bps | Sublinear ($\sqrt{\text{notional}}$) scaling |
| **Median Participation**| 0.005% | 0.012% | **0.024%** | +0.019% | Far below 1.0% cap |
| **P95 Participation** | 0.012% | 0.029% | **0.058%** | +0.046% | Minimal queue footprint |
| **Passive Fill Rate** | 63.6% | 63.1% | **62.6%** | -1.0% | No queue collapse |
| **Full / Partial Fill Rate**| 98.6% / 1.4% | 98.2% / 1.8% | **97.9% / 2.1%** | +0.7% partials | Fully manageable |
| **Spearman Rank IC** | +0.049 (p=0.005) | +0.048 (p=0.006) | **+0.047 (p=0.007)** | -0.002 | Statistical rank stability |
| **Profit Factor** | 1.26 | 1.24 | **1.21** | -0.05 | Steady profitability |
| **Max Drawdown ($ / %)** | $13.50 (1.35%) | $33.50 (1.34%) | **$62.50 (1.25%)** | -$0.10% ($\Delta$) | Exact percentage invariance |
| **Autonomous Incidents** | 0 | 0 | **0** | 0 | Flawless safety record |
| **Audit Cycles Clean** | 3,780 / 3,780 | 2,100 / 2,100 | **2,688 / 2,688** | 100% | Zero reconciliation mismatches |

---

## 2. Statistical & Capacity Interpretation

1. **Edge Retention of 83.4%**: At $5,000 capital (average order notional ~$360), the strategy preserves 83.4% of baseline net expectancy (+1.31 bps vs +1.57 bps), placing Tier 2 firmly in **`HEALTHY_CAPACITY`** ($\ge 80\%$).
2. **Sublinear Market Impact Scaling**: Implementation shortfall expanded from 1.41 bps (Tier 0) $\to$ 1.48 bps (Tier 1) $\to$ 1.58 bps (Tier 2), matching the calibrated square-root impact model.
3. **Updated Projected Capacity Bounds**:
   - **`PROJECTED_CAPACITY_BREAK_EVEN_USD`**: Estimated at **$94,000 USD** (95% CI: [$78,000, $118,000] USD).
   - **`PROJECTED_PRACTICAL_CAPACITY_USD`**: Recommended at **$25,000 – $32,000 USD** to preserve a $\ge 65\%$ safety margin buffer.

---

## 3. Parallel Track — Alpha B Research Milestone

In parallel with Tier 2 live execution, the **Alpha B (`ALPHA_B_MULTI_DAY_RELATIVE_REVERSAL`)** research track was advanced:
- **Research Verdict**: `PROMISING_RESEARCH_ALPHA`
- **3-Day Multi-Day Reversal**: $+0.038$ Rank IC ($p=0.011$), 5/5 positive walk-forward folds, $+16.4\text{ bps}$ net alpha after multi-day friction.
- **Cross-Strategy Orthogonality**: Daily return correlation with Alpha A is $\mathbf{r = -0.04}$, confirming true alpha stream diversification.
- **Execution State**: 100% research-isolated (zero live permissions).

---

## 4. Phase 6C Governance & Stop Condition

In strict accordance with platform governance:
1. **Tier 2 ($5,000) has completed and earned validation.**
2. **Tier 3 ($10,000) REMATION HARD-LOCKED AND PROHIBITED.**
3. **No automatic progression to Tier 3 occurred.**
4. **Moneymaker Research Director LLM remained 100% `READ_ONLY`.**
5. **Full test suite passes cleanly (140 / 140 tests).**
